Lab to Label: Translating Clinical Evidence into Regulatory & Product Labelling
Nomita Saxena
About Me
An experienced regulatory writing consultant, she brings 20+ years in medicine and pharma R&D, with leadership roles at AstraZeneca, Novo Nordisk, and Accenture. She specializes in clinical and regulatory documentation and now partners with global clients to deliver high-impact content and capability-building programs.Courses by me
Participants will gain the ability to interpret scientific and clinical evidence, develop regulatory documentation across the drug development lifecycle, and translate validated clinical data into compliant product labelling and regulatory submissions.
Participants will gain the ability to perform strategic reviews of medical and regulatory documents, identify quality gaps, ensure consistency across complex documentation, and strengthen compliance with regulatory writing standards.
Participants will gain the ability to use artificial intelligence tools to support literature analysis, draft scientific and regulatory documents, enhance clarity and consistency in medical writing, and implement responsible workflows that align with pharmaceutical compliance and documentation standards.
Participants will gain ability to interpret lay summary regulatory requirements, write compliant and patient-friendly summaries, apply plain-language principles without scientific distortion, manage review and feedback cycles, and ensure submission-ready disclosure aligned with global health authority expectations.
Participant will be able to learn the capability to plan, write, review, and finalize compliant CSRs aligned with regulatory expectations, ensuring clarity, accuracy, and submission readiness.